CTSH
46
4
WDC
30
-7
DLTR
51
5
IVZ
43
4
AVY
53
3
A
43
2
WHR
50
3
PRU
64
4
EMN
48
3
STX
52
3
AXP
63
3
FITB
62
3
WAT
48
5
ESS
51
4
FE
52
-8
EXPE
80
16
EBAY
43
-9
CCL
60
2
IPG
45
-4
PH
70
4
CTSH
46
4
WDC
30
-7
DLTR
51
5
IVZ
43
4
AVY
53
3
A
43
2
WHR
50
3
PRU
64
4
EMN
48
3
STX
52
3
AXP
63
3
FITB
62
3
WAT
48
5
ESS
51
4
FE
52
-8
EXPE
80
16
EBAY
43
-9
CCL
60
2
IPG
45
-4
PH
70
4
Financhill
Back

Concentra Group Holdings Parent Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
25

CON
Concentra Group Holdings Parent

Last Price:
$21.12
Seasonality Move:
--
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
25
Concentra Group Holdings Parent (CON) is a Sell

Is Concentra Group Holdings Parent a Buy, Sell or Hold?

  • The current Concentra Group Holdings Parent [CON] share price is $21.49. The Score for CON is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • CON is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CON Stock Price Chart

What is Concentra Group Holdings Parent's stock price today?

  • The Concentra Group Holdings Parent share price today is $21.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CON is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

CON Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 46.73 Sell
Chaikin Money Flow: 473200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.11 - 23.05) Sell
Bollinger Bands (100): (20.08 - 22.7) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

CON Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21 Buy
20-day SMA: 21.79 Sell
50-day SMA: 22.29 Sell
200-day SMA: 0 Buy
8-day EMA: 21.2 Buy
20-day EMA: 21.62 Sell
50-day EMA: 21.86 Sell
200-day EMA: 0.42 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Concentra Group Holdings Parent Earnings Growth & CON Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.12 per share, and an increase next year of $0.24 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Concentra Group Holdings Parent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):